The Room will open about 15 minutes before the next webinar starts!
The link to the room will appear here when the room open!
5/2/2021: SUNDAY 7pm Eastern Time. Topic: Convection-enhanced Delivery of OS2966 for Treatment of Recurrent High Grade Glioma - A Window of Opportunity Trial" Anne-Marie Carbonell, MD: Dr. Carbonell trained in neurosurgery at the Cleveland Clinic prior to Co-Founding OncoSynergy, a clinical-stage biotechnology company developing therapeutics to improve outcomes for patients suffering from the worst cancers - starting first with glioblastoma. She currently serves as the CEO and Chief Medical Officer of OncoSynergy and lead the FDA IND approval of OncoSynergy's first-in-human study in recurrent high-grade glioma.
and Michael Vogelbaum, MD, PhD: Dr. Vogelbaum is an internationally known leader in neurosurgical oncology and distinguished investigator in laboratory research, translational and clinical trials in gliomas. He is currently Chief of Neurosurgery and Program Leader of the Department of Neuro-Oncology at Moffitt Cancer Center.
5/16/21: SUNDAY 7pm Eastern Time. Topic: Perfusion MRI of Brain Tumors
Mark Shiroishi, MD, MS
Neuroradiologist and Assistant Professor in the USC Department of Radiology
5/23/21: SUNDAY 7pm Eastern Time. Topic: A New Hope in Treating Metastatic Brain Tunmors: Recent Advances and Opportunities
Hussein A. Tawbi, M.D., Ph.D.
Co-Director, Brain Metastasis Clinic, Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center, Houston, TX
5/30/21: SUNDAY 7pm Eastern Time. Topic: Musella Foundation Projects: Clinwiki, Patient Navigation, Promising Pathway Act
Al Musella, DPM, President, Musella Foundation
Erika Vial Monteverdi, Executive Director, Cancer Commons
Tim Stuhlmiller, Director of Scientific Strategy, xCures, Inc
William Hoos, CCO, xCures, Inc.